跳至主要内容
临床试验/NCT06301893
NCT06301893招募中不适用

Prevalence and Mapping of Sickle Cell Trait and Disease in Uganda

Children's Hospital Medical Center, Cincinnati4 个研究点 分布在 1 个国家目标入组 1,000,000 人开始时间: 2013年9月7日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
1,000,000
试验地点
4
主要终点
Incidence of HbSS and HbA

研究概览

简要总结

It is estimated that over 250,000 babies are born with sickle cell disease (SCD) annually in sub-Saharan Africa, and only 10% - 50% of them survive beyond five years of age. Data describing the magnitude of the sickle cell problem are lacking in most African countries. The available data on prevalence were mainly from older studies and small numbers of hospitalized patients. In Uganda, approximately 25,000 children are born with SCD but 70-80% die before their 5th birthday. Lehmann and Raper found 'sicklaemia' prevalence of 0.8% and 45% in the Sebei and Bambaa ethnic groups, respectively. A recent study found a SCT and SCD prevalence of 3% - 19% and 0% - 3%, respectively but this study addressed only 5 of Uganda's 111 districts and used a small convenience sample of children aged 6 - 60 months. The objective of this study is to determine the prevalence and map out the burden of SCT and SCD in Uganda.

详细描述

The investigators propose a cross-sectional study of sickle cell trait (SCT) and disease in all districts of Uganda using dried blood spots (DBS) collected from HIV exposed babies over a 12-month period. About 90,000 DBS samples collected from HIV exposed children from all districts of Uganda from February 2014 to March 2015 will be analyzed. Follow-up analysis will occur on up to 1,000,000 samples collected during 2015 - 2030 based on surveillance findings and secondary objectives. The study will be conducted at the Central Public Health (CPHL) in Kampala where the samples from across the country are collected for PCR testing. The investigators will perform hemoglobin analysis using isoelectric focusing (IEF). The overall prevalence and the prevalence by district of SCT and SCD will be determined. Geospatial mapping will be performed using a specialized software program to produce a map illustrating the prevalence of SCT and SCD throughout the country and allow associations between sickle cell trait/disease with either malaria prevalence or HIV co-morbidity. Further analysis of sickle cell disease or hemoglobin variants will be conducted using HPLC and DNA-based techniques.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
— 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • Up to 1,000,000 samples may be collected during 2015 - 2030 following primary analysis based on surveillance findings.

排除标准

  • Repeat samples on the same individuals during the study period will be excluded.

结局指标

主要结局

Incidence of HbSS and HbA

时间窗: February 2014 to March 2015

Incidence of sickle cell disease (HbSS) and sickle cell trait (HbA)

次要结局

  • Incidence of HbSS and HbA(March 2015 - March 2030)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Uganda Sickle Surveillance Study (US-3) | 临床试验